JP2018524361A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524361A5 JP2018524361A5 JP2018500814A JP2018500814A JP2018524361A5 JP 2018524361 A5 JP2018524361 A5 JP 2018524361A5 JP 2018500814 A JP2018500814 A JP 2018500814A JP 2018500814 A JP2018500814 A JP 2018500814A JP 2018524361 A5 JP2018524361 A5 JP 2018524361A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- antibody
- amino acid
- seq
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021142739A JP7366093B2 (ja) | 2015-07-14 | 2021-09-01 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562192173P | 2015-07-14 | 2015-07-14 | |
| US62/192,173 | 2015-07-14 | ||
| PCT/JP2016/003337 WO2017010106A1 (en) | 2015-07-14 | 2016-07-14 | A therapeutic agent for a tumor comprising an ido inhibitor administered in combination with an antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021142739A Division JP7366093B2 (ja) | 2015-07-14 | 2021-09-01 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018524361A JP2018524361A (ja) | 2018-08-30 |
| JP2018524361A5 true JP2018524361A5 (https=) | 2019-08-08 |
Family
ID=57757291
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500814A Ceased JP2018524361A (ja) | 2015-07-14 | 2016-07-14 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
| JP2021142739A Active JP7366093B2 (ja) | 2015-07-14 | 2021-09-01 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021142739A Active JP7366093B2 (ja) | 2015-07-14 | 2021-09-01 | 抗体と併用投与されるｉｄｏ阻害剤含有腫瘍治療剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20180271861A1 (https=) |
| EP (2) | EP3991749A3 (https=) |
| JP (2) | JP2018524361A (https=) |
| KR (1) | KR102823683B1 (https=) |
| CN (1) | CN107847597A (https=) |
| AU (1) | AU2016293667A1 (https=) |
| CA (1) | CA2992238A1 (https=) |
| HK (1) | HK1252514A1 (https=) |
| TW (1) | TW201713332A (https=) |
| WO (1) | WO2017010106A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3070295A1 (en) | 2017-07-28 | 2019-01-31 | Phanes Therapeutics, Inc. | Anti-tim-3 antibodies and uses thereof |
| CN112601526B (zh) * | 2018-08-29 | 2025-10-03 | 凯莫森特里克斯股份有限公司 | 使用c-c趋化因子受体4(ccr4)拮抗剂和一种或多种检查点抑制剂的联合治疗 |
| US11839659B2 (en) | 2020-07-02 | 2023-12-12 | Northwestern University | Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein |
| CN112961239B (zh) * | 2021-02-24 | 2021-09-10 | 北京昭衍生物技术有限公司 | Tim抑制剂及其应用 |
| WO2022184930A2 (en) | 2021-03-05 | 2022-09-09 | Universität Basel | Compositions for the treatment of ebv associated diseases or conditions |
| EP4052705A1 (en) | 2021-03-05 | 2022-09-07 | Universität Basel Vizerektorat Forschung | Compositions for the treatment of ebv associated diseases or conditions |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5677A (en) | 1848-07-25 | Improvement in hillside-plows | ||
| US171A (en) | 1837-04-20 | Machine for washing iron and other ores | ||
| US5821A (en) | 1848-10-03 | Cream-freezer | ||
| US4968A (en) | 1847-02-13 | Spinal elevator | ||
| US337A (en) | 1837-07-31 | Mode of constructing railroad-frogs | ||
| US603A (en) | 1838-02-15 | Improvement in the construction of many-chambered fire-arms | ||
| US6066322A (en) | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
| WO1999029310A2 (en) | 1997-12-05 | 1999-06-17 | Medical College Of Georgia Research Institute, Inc. | Regulation of t cell-mediated immunity by tryptophan and its analogs |
| CN100455599C (zh) | 2000-03-03 | 2009-01-28 | 协和发酵工业株式会社 | 基因重组抗体及其抗体片段 |
| PT1449850E (pt) | 2001-08-31 | 2011-02-02 | Kyowa Hakko Kirin Co Ltd | Anticorpos humanos enxertados em rdc¿s e fragmentos desses anticorpos |
| AU2003303082B2 (en) | 2002-01-30 | 2009-07-02 | Dana-Farber Cancer Institute, Inc. | Compositions and methods related to TIM-3, a Th1-specific cell surface molecule |
| WO2005057341A2 (en) | 2003-12-02 | 2005-06-23 | Koolspan, Inc. | Automatic hardware-enabled virtual private network system |
| PL1879573T3 (pl) | 2005-05-10 | 2013-05-31 | Incyte Holdings Corp | Modulatory 2,3-dioksygenazy indoloaminy i sposoby ich zastosowania |
| CA2682382A1 (en) * | 2007-03-28 | 2008-10-09 | Biogen Idec Inc. | Non-fucosylated antibodies |
| CA2965198C (en) | 2008-01-15 | 2021-02-16 | The Board Of Trustees Of The Leland Stanford Junior University | Markers of acute myeloid leukemia stem cells |
| PL2315756T3 (pl) * | 2008-07-08 | 2015-02-27 | Incyte Holdings Corp | 1,2,5-oksadiazole jako inhibitory 2,3-dioksygenazy indoloaminy |
| WO2010053182A1 (ja) | 2008-11-10 | 2010-05-14 | 協和発酵キリン株式会社 | キヌレニン産生抑制剤 |
| US8492119B2 (en) * | 2009-04-27 | 2013-07-23 | Kyowa Hakko Kirin Co., Ltd | Antibody to human IL-3 receptor alpha chain |
| CA2773579C (en) | 2009-09-10 | 2019-01-15 | Kyowa Kirin Co., Ltd. | Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4) |
| WO2011042065A1 (en) | 2009-10-09 | 2011-04-14 | Daniel Monsch | "momoheli" lifting module and vehicles |
| TWI535442B (zh) * | 2010-05-10 | 2016-06-01 | Kyowa Hakko Kirin Co Ltd | A nitrogen-containing heterocyclic compound having an action of inhibiting the production of canine erythritine |
| WO2011155607A1 (ja) * | 2010-06-11 | 2011-12-15 | 協和発酵キリン株式会社 | 抗ｔｉｍ－３抗体 |
| JP6047497B2 (ja) | 2011-11-09 | 2016-12-21 | 協和発酵キリン株式会社 | 含窒素複素環化合物 |
| JP6224619B2 (ja) * | 2012-12-07 | 2017-11-01 | 協和発酵キリン株式会社 | 抗ｆｏｌｒ１抗体 |
| CN105209449B (zh) * | 2013-03-14 | 2019-02-01 | 库拉德夫制药私人有限公司 | 犬尿氨酸途径的抑制剂 |
| EA029126B1 (ru) | 2013-07-01 | 2018-02-28 | Бристол-Майерс Сквибб Компани | Ингибиторы ido |
| DK3066085T3 (da) * | 2013-11-08 | 2020-06-02 | Incyte Holdings Corp | Fremgangsmåde til syntesen af en indolamin-2,3-dioxygenaseinhibitor |
| EP3153178A4 (en) | 2014-06-06 | 2017-12-20 | Kyowa Hakko Kirin Co., Ltd. | Method for treating cancer patients using folr1 targeted drug and antifolate, and drug |
-
2016
- 2016-07-14 HK HK18111823.0A patent/HK1252514A1/zh unknown
- 2016-07-14 EP EP21199914.9A patent/EP3991749A3/en active Pending
- 2016-07-14 EP EP16824090.1A patent/EP3322444A4/en not_active Withdrawn
- 2016-07-14 TW TW105122337A patent/TW201713332A/zh unknown
- 2016-07-14 JP JP2018500814A patent/JP2018524361A/ja not_active Ceased
- 2016-07-14 CA CA2992238A patent/CA2992238A1/en active Pending
- 2016-07-14 WO PCT/JP2016/003337 patent/WO2017010106A1/en not_active Ceased
- 2016-07-14 US US15/744,322 patent/US20180271861A1/en not_active Abandoned
- 2016-07-14 AU AU2016293667A patent/AU2016293667A1/en not_active Abandoned
- 2016-07-14 KR KR1020187001434A patent/KR102823683B1/ko active Active
- 2016-07-14 CN CN201680041307.3A patent/CN107847597A/zh active Pending
-
2021
- 2021-09-01 JP JP2021142739A patent/JP7366093B2/ja active Active
- 2021-11-05 US US17/519,990 patent/US20220088011A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108025051B (zh) | 包含抗pd-1抗体分子的联合疗法 | |
| JP2018524361A5 (https=) | ||
| JP2023039448A (ja) | がんを治療するための、ｐｄ－１アンタゴニスト及びｖｅｇｆｒ／ｆｇｆｒ／ｒｅｔチロシンキナーゼ阻害剤の組合せ | |
| JP6877339B2 (ja) | Ｐｄ−ｌ１に対する抗体分子およびその使用 | |
| KR102833068B1 (ko) | Pd-1에 대한 항체 분자 및 그의 용도 | |
| KR20200089286A (ko) | 조합 요법 | |
| RU2019138337A (ru) | Конъюгаты на основе антитела, содержащие агонист toll-подобного рецептора, и виды комбинированной терапии | |
| JP2019506403A5 (https=) | ||
| EP3303399A1 (en) | Methods of treating cancer using anti-ox40 antibodies | |
| JP7402691B2 (ja) | 抗ｃｄ２５抗体薬物複合体による併用療法 | |
| JP2019501151A5 (https=) | ||
| KR20160108568A (ko) | 암을 치료하기 위한 pd-1 길항제 및 ido1 억제제의 조합 | |
| CN105451770A (zh) | 使用PD-1拮抗剂和dinaciclib的组合治疗癌症 | |
| JP2023531676A (ja) | ３－（１－オキソイソインドリン－２－イル）ピぺリジン－２，６－ジオン誘導体を含む投与レジメン | |
| JP2023500575A (ja) | 癌を治療するためのＰＤ－１アンタゴニスト、ＶＥＧＦＲ／ＦＧＦＲ／ＲＥＴチロシンキナーゼ阻害剤、及びＣＢＰ／β－カテニン阻害剤の組合せ | |
| JP2019517485A5 (https=) | ||
| AU2018328015A1 (en) | Compounds for reducing the viscosity of biological formulations | |
| JP2020522543A5 (https=) | ||
| JP2025156341A (ja) | ＰＤ－１アンタゴニスト、ＨＩＦ－２α阻害剤およびレンバチニブまたはその薬学的に許容され得る塩の組み合わせを使用して、癌またはフォンヒッペル・リンダウ病を処置するための方法 | |
| JP2022530241A (ja) | Ｃｄｋ阻害剤と組み合わせたｒａｎｋ経路阻害剤 | |
| JP2022534889A (ja) | Ｃｄｋ阻害剤を使用した組合せ療法 | |
| JP2024521696A (ja) | 併用治療のためのがん患者を同定するための方法 | |
| US10064939B2 (en) | Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibitor resistant cancers | |
| TW202313033A (zh) | 組合療法 | |
| CA3220380A1 (en) | Combination treatment of cancer |